QMXGF Stock UPDATES Qmx Gold Corp (QMXGF) 0.0570 08/11/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Qmx Gold Corp (QMXGF) 0.0570 $QMXGF

QMX Gold Agrees to Extend the Closing on the Sale of the Snow Lake Property
Marketwire - Mon Jul 07, 8:01PM CDT
QMX Gold Corporation (TSX VENTURE: QMX) ("QMX" or the "Company" and Northern Sun Mining Corp. ("Northern Sun" have agreed to an extension of the closing of the proposed acquisition by Northern Sun of the Snow Lake property, detailed in the press release dated October 2, 2013. The closing is now expected to occur on or before September 30, 2014.

QMX Reports Revenue of $9.1 Million and Operational Cash Flow of $2.28 Million for Q1 2014
ACCESSWIRE - Tue Jun 03, 4:01PM CDT
Toronto, ON / ACCESSWIRE / June 3, 2014 / QMX GOLD CORPORATION (TSXV:QMX)("QMX" or the "Company" is reporting Q1 2014 production of 6,171 ounces of gold from the Lac Herbin mine in Val D'Or, Quebec, a 49% increase over Q1 2013. The mine generated revenue of $9.1 million on the sale of 6,734 ounces of gold at an average realized price of $1,423 per ounce. All figures are reported in Canadian dollars, unless noted otherwise.

QMX Reports Revenue of $30.62 Million and Operational Cash Flow of $5.45 Million for 2013
Marketwire - Tue Apr 01, 7:04AM CDT
QMX GOLD CORPORATION (TSX VENTURE: QMX) ("QMX" or the "Company" sold 22,209 ounces of gold at an average price of $1,428 for revenue of $30.62 million in 2013. All figures are reported in Canadian dollars, unless noted otherwise.

QMX Gold Produces Over 22,000 Ounces of Gold in 2013 from Lac Herbin Mine
Marketwire - Tue Feb 25, 6:04AM CST
QMX GOLD CORPORATION (TSX VENTURE: QMX) ("QMX Gold" or the "Company" produced approximately 7,260 ounces of gold from its Lac Herbin Mine in Val D'Or, Quebec in the fourth quarter of 2013. This brings total production for 2013 to over 22,200 ounces of gold, in line with Company guidance. Full financial details will be released in March 2014.

QMX to Begin Trading on TSX Venture Exchange on February 20, 2014
Marketwire - Tue Feb 18, 6:02AM CST
QMX GOLD CORPORATION (TSX: QMX) ("QMX Gold" or the "Company" announces that its common shares (the "Shares" have been approved for listing on the TSX Venture Exchange. The Shares will be delisted from the Toronto Stock Exchange at the close of business on Wednesday, February 19, 2014 and commence trading on the TSX Venture Exchange at the open of business on Thursday, February 20, 2014 under the ticker symbol QMX.

QMX Continues Trading on the TSX Until February 24, 2014
Marketwire - Mon Feb 10, 6:01AM CST
QMX GOLD CORPORATION (TSX: QMX) ("QMX Gold" or the "Company" has received notice from the TSX that common shares of the Company will continue trading on the TSX until February 24, 2014 while the Company continues to pursue listing of its common shares on the TSX Venture Exchange as outlined in the press releases dated December 10th and 11th, 2013. While a listing on the TSX Venture Exchange is not guaranteed, this extension helps a smooth transition of the listing of the Company's common shares from the TSX without a disruption in trading.

Best's Rating Notification - Mercury County Mutual Insurance Company
Rating Division - AMBest - Fri Jan 31, 10:34AM CST
A.M. Best Company has made the following rating update:

QMX Gold Extends Loan Facility With Third Eye Capital
Marketwire - Tue Jan 28, 4:31PM CST
QMX GOLD CORPORATION (TSX: QMX) ("QMX Gold" or the "Company" and Third Eye Capital Corporation ("TEC" have signed an amending agreement that will further extend the term of the bridge loan facility provided by TEC until March 31, 2014 and be subject to the same terms and conditions outlined in the Company's press release dated October 9th, 2013.

Global Orphan Drug Pipeline Analysis
M2 - Fri Jan 17, 3:54AM CST
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry. With close to 65-70 Million people in the US & Europe having some kind of rare disease complaints, the increasing activities around the development of orphan drugs only imply that the appropriate treatments for unmet needs are increasing, thus increasing the profit margins in the future. As the Asian pharmaceutical markets are still in growth stage, the opportunities for orphan drugs in Asia are also immense and getting increasingly popular. It is expected that by 2020, the Asian orphan drugs market would witness steady growth.

QMX Gold Agrees to Extend Closing on the Sale of Snow Lake Property
Marketwire - Wed Jan 15, 7:30AM CST
QMX GOLD CORPORATION (TSX: QMX) ("QMX Gold" or the "Company" and Northern Sun Mining Corp., formerly Liberty Mines Inc. ("Northern Sun" , have agreed to an extension of the closing of the proposed acquisition by Northern Sun of the Snow Lake property, detailed in the press release dated October 2, 2013. The closing is now expected to occur on or before March 31, 2014. The execution of the agreement remains subject to a number of conditions, including without limitation, receipt all necessary government and regulatory approvals in Canada and China, completion of due diligence, and Northern Sun securing the financing necessary to complete the acquisition. Additionally, QMX Gold has agreed to waive the extension fee of $100,000 set out in the original sale agreement.

QMX Confirms Application for Stock to Begin Trading on TSX Venture Post TSX Delisting
Marketwire - Wed Dec 11, 11:07AM CST
QMX GOLD CORPORATION (TSX: QMX) ("QMX Gold" or the "Company" announces that, further to the press release dated December 10, 2013, the Company confirms that it intends to list its common shares on the TSX Venture Exchange (the "TSX-V" .




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 657

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 552

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 248

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 419

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 375

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 488

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 348

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 100

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading

Top 5 Most Recently Viewed Articles

Orchestra BioMed Achieves Major Milestones in Q2 Progress

Updated Category News Views 147

Orchestra BioMed Reports Strong Financial Performance Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO), a pioneering biomedical innovation firm, recently announced notable financial results for the second quarter of 2025. The company has made significant strides in securing over $111 million in proceeds from strategic transactions and concurrent public and private equity...

Continue Reading
Euhomy Unveils Innovative Portable Ice Makers at CES 2026

Updated Category News Views 225

Exciting Innovations from Euhomy at CES 2026 CES 2026 is the stage where Euhomy introduces four remarkable portable ice makers. Each model is thoughtfully crafted to suit various occasions, whether it’s a lively outdoor BBQ, an elegant cocktail gathering, or a quiet evening relaxing at home. The Euhomy products are designed to elevate every drink with fresh and...

Continue Reading
American Regent Recalls Papaverine Injection Nationwide

Updated Category News Views 52

When Glass and Medicine Don't Mix Walking a tightrope in pharmaceutical production is no small feat, but American Regent, Inc. just stepped off the safety line with a recall of their Papaverine Hydrochloride Injection. We're talking visible glass and paraformaldehyde floating in those vials like unwelcome party guests. That's a gamble nobody wants to take, especially when...

Continue Reading
AIxCrypto Strengthens Legal Team with Andrew Grossman Appointment

Updated Category News Views 109

AIxCrypto Appoints Andrew Grossman as Head of Legal A recent transformation is underway at AIxCrypto Inc. This innovative company, recognized on the Nasdaq under the ticker AIXC, has elevated its legal operations with the appointment of Andrew Grossman as Head of Legal. Grossman’s role will encompass pivotal responsibilities in legal, compliance, and governance...

Continue Reading
Innovative Urine-Absorbing Accessory Developed for Men

Updated Category News Views 178

Revolutionary Invention to Combat Urine Leaks An inventor from Maryland has created a new accessory, LAST DROP, specifically designed to absorb urine leaks. The inspiration stemmed from personal experiences with prostate cancer, highlighting the need for improved comfort and hygiene for men dealing with this sensitive issue. Features and Benefits of LAST DROP LAST DROP...

Continue Reading